About
bioProtonics' µTexture in vivo, MR-based diagnostic provides the resolving power needed to measure the ultra fine tissue changes that are the earliest harbingers of disease, thus enabling most effective application of therapeutics. µTexture is: Clinically robust—works in the "real world" Fits seamlessly into MRI radiology workflow One minute added sequence Software implementation no expensive hardware required Readily operable by any scan technician
Technologies
Outlook
Google Cloud Hosting
Shutterstock
Wix
Varnish
Mobile Friendly
Remote
AI
IoT
Keywords
medical imaging
medical equipment manufacturing
spectral wavelength targeting
dicom compatibility
medical diagnostics
mri software
medical equipment and supplies manufacturing
patient safety improvements
spectral response in pathology
spectral wavelength analysis
ai analytics in mri
ai-powered diagnostics
spectral data integration
medical devices
tissue microarchitecture
medical data analytics
spectral imaging in mri
digital biopsy
medical imaging workflow
spectral data analysis
spectral data correlation
cost reduction in diagnostics
workflow automation
b2b
tissue texture analysis
early cancer detection
microstructure imaging
healthcare ai solutions
ai diagnostic software
early disease detection
Company Information
-
Employees 9
-
Founded 2018
-
Total Funding $5709676
Location
27 W Anapamu St, Santa Barbara, California, United States, 93101
